Search for: "STATE v VISSER" Results 21 - 40 of 212
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jan 2024, 3:40 am by Katie Cambrook (Bristows)
A copy of the judgment can be found here [1] C-130/11 [2] C-673/18 [3] Merck Sereno v Comptroller General of Patents [2023] EWHC 3240 (Ch) [4] C-61/79 More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Artificial Intelligence and Patents: An International Perspective on… [read post]
23 Jan 2024, 2:32 am by Rebekka Thomas (Bristows)
On 19 December 2023, the Court of Appeal handed down its decision in The NOCO Company v Shenzhen Carku Technology Co., Ltd  [2023] EWCA Civ 1502. [read post]
27 Dec 2023, 5:51 am by Myles Jelf (Bristows)
A further set of complications as between validity and infringement arose in Edwards v Meril, this time not courtesy of the CMS. [read post]
8 Dec 2023, 5:35 am by Ivo Emanuilov (KU Leuven)
The facts of the case On 21 November 2023, Sir Anthony Mann of the London High Court handed down a judgment in the case of Emotional Perception AI Ltd v Comptroller-General of Patents, Designs and Trade Marks [2023] EWHC 2948 (Ch). [read post]
4 Dec 2023, 7:14 am by Kluwer Patent blogger
Thus, with its order of July 11, 2023, it allowed an appeal to proceed (see case C-93/23, EUIPO v Neoperl). [read post]
3 Nov 2023, 7:15 am by David Hemming (Bristows)
The starting point for Mellor J’s analysis was Kitchin LJ’s judgment in Regeneron v Genentech [2013] EWCA Civ 93. [read post]
20 Sep 2023, 7:13 am by Kluwer Patent blogger
Importantly, today’s ruling does not impact NanoString’s legal ability to market or sell CosMx SMI products for protein detection in the European Union, nor does it impact the lawful selling of any NanoString CosMx SMI products in the United States, the United Kingdom or the rest of the world outside of the EU member states participating in the UPC system. [read post]
20 Sep 2023, 7:13 am by Kluwer Patent blogger
Earlier, an ex parte PI order was granted by the UPC Local Division Dusseldorf in June 2023 (ORD_ 541204/2023, in the case of myStromer AG v Revolt Zycling AG), The order in the 10x Genomics case was issued yesterday by Presiding Judge Matthias Zigann at the Munich local division of the UPC. [read post]
Case date: 09 May 2023 Case number: No. 22-1291 Court: United States Court of Appeals, Federal Circuit, A full summary of this case has been published on Kluwer IP Law. [read post]
26 Aug 2023, 9:16 am by Kluwer Patent blogger
Also, one can search for patents and what the state of affairs is concerning opt outs, oppositions and UPC cases. [read post]
The board’s claim construction and motivation to combine analysis were supported by the record (Shamoon v. [read post]
2 Aug 2023, 2:14 am by Kate O’Sullivan (Bristows)
On 25 July 2023, the Court of Appeal handed down its decision in Teva & Sandoz v Astellas[1] concerning the validity of Astellas’ patent to mirabegron for use in the treatment of overactive bladder (“OAB”). [read post]
30 Jul 2023, 3:05 am by Laurence Lai (Simmons & Simmons LLP)
  Country of origin: new European applications in 2022 v requests for unitary effect   On the other hand, proprietors from Asia and the US appear overall less enthusiastic relative to their proportion of European filings. [read post]
25 Jul 2023, 1:43 am by Matthieu Dhenne (Dhenne Avocats)
Or that the credibility of the technical effect is assessed at the priority or filing date (e.g., TGI Paris, October 6, 2009, RG n°07/16446, Teva v. [read post]